Content about Treatment of bipolar disorder

March 8, 2013
Oceans Omega introduces omega-infused water

Oceans Omega launched its omega-3 EPA/DHA enhanced water product, branded Omega Infusion, into 100 H-E-B stores with Healthy Living Departments, the company announced.

February 27, 2013
Nordic Naturals, Lipid Technologies partner on omega-3 blood test distribution to doctors

Nordic Naturals and Lipid Technologies on Tuesday developed a partnership to ensure that practitioners have easy access to the Holman Omega-3 Blood Spot Test for their patients.

January 29, 2013
Oceans Omega launches omega-3 enhanced water

Oceans Omega launched Omega Infusion, an omega-3 EPA/DHA enhanced water product with initial placement within Giant Food.

November 14, 2012
CSPN, Dara BioSciences enter distribution contract for breast cancer drug

The Community Specialty Pharmacy Network has entered a contract with Dara BioSciences to distribute a nonsteroidal anti-estrogen product.

September 12, 2012
CRN debunks omega-3 meta-analysis as 'inherently inconclusive'

As part of a meta-analysis spanning 70,000 patients, a study published in the Sept. 12 issue of JAMA determined supplementation with omega-3 fish oils was not associated with a lower risk in heart disease.

August 14, 2012
Nordic Naturals overhauls labeling system for professional product line

Nordic Naturals on Tuesday rolled out a brand new look across its professional product line with a new classification system to better assist selection.

August 10, 2012
Mylan launches generic sleep disorder, bipolar disorder drugs

Mylan has launched a generic drug used to treat sleep disorders, the company said Friday.

June 26, 2012
Supernus gets preliminary nod for epilepsy drug

The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

June 18, 2012
Greenstone launches generic Zyprexa

Greenstone, the generic pharmaceutical subsidiary of Pfizer, has launched olanzapine tablets.

June 12, 2012
Nordic Naturals targets vegetarians with new omega-3 supplement

Nordic Naturals on Tuesday introduced Algae Omega, a solution for vegetarians seeking the health benefits of marine omega-3s. Made from sustainably sourced microalgae and available in both soft gels and liquid, the product offers an algae-based source of beneficial marine omega-3 essential fatty acids without the use of fish.

May 8, 2012
Reports: Court upholds Abilify patent

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

April 25, 2012
Sun launches generic version of Zyprexa

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

April 24, 2012
Dr. Reddy's launches generic version of Zyprexa

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

April 24, 2012
Mylan launches generic schizophrenia, bipolar disorder drug

Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

March 28, 2012
Three generic versions of psychiatric drug launched

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

March 5, 2012
Dr. Reddy's launches generic version of Pfizer's Geodon

Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

February 3, 2012
Teva launches generic schizophrenia, bipolar disorder drug

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

December 14, 2011
FDA advisory committee recommends approval for schizophrenia, bipolar disorder drug

A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

November 10, 2011
Study: Omega-3s credited with lowering inflammation, anxiety

A recent study gauging the impact of consuming more fish oil showed a marked reduction both in inflammation and in anxiety among a cohort of healthy young people, the Ohio State University Center for Clinical and Translational Science announced Wednesday.

October 27, 2011
Innopharma receives FDA approval for generic Zyprexa injection

A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

October 24, 2011
FDA approves generic versions of Zyprexa

The Food and Drug Administration has approved the first generic versions of two drugs made by Eli Lilly for treating schizophrenia and bipolar disorder, the agency said Monday.

October 20, 2011
Prasco to market authorized generic Zyprexa

Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

October 19, 2011
Gone fishing

There’s a new fish oil on the market, and one that doesn’t have a chance at producing a fish “burp” — krill oil.

October 7, 2011
AstraZeneca settles with generic drug makers over Seroquel XR

Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

October 7, 2011
Breast cancer drug may increase diabetes risk among older women

A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

© 2013 Drug Store News. All Rights Reserved.